Strike Ends at Shasun API Plant but Share Price Takes Hit

- Last updated on GMT

Related tags: Active pharmaceutical ingredient, Bombay stock exchange, Stock, Stock market

Strike Ends at Shasun API Plant but Share Price Takes Hit
Operations have restarted at one of Shasun’s API facilities in India following a strike last month.

The strike – which was deemed ‘illegal’ by the firm when it began on June 15​ at the Puducherry, India API (active pharmaceutical ingredient) and finished formulation plant – led to the halting of production, including ibuprofen which is manufactured from the site, with operations recommencing only after 12 days.

In a regulatory filing​, the company said: “Shasun Pharmaceuticals Ltd has informed BSE [the Bombay Stock Exchange] that an amicable settlement has been reached with the workers at the Company's Pondicherry facility.

“The strike has been called off and operations resumed from yesterday night [June 27].”

The company has not revealed what the twelve days of striking may have cost though a 15-day strike over wage settlements at the same facility in May 2011 cost an estimated INR 50m ($853,000).

However, the company’s share prices reached a 52-week low on June 26 as the firm felt the full effect of the workers’ strike.

Related news

Show more

Related products

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers